Effects of sevelamer hydrochloride (Renagel®) and calcium acetate on controlling serum phosphorus in peritonel dialysis patients

被引:0
|
作者
Evenepoel, Pieter
Selgas, Rafael
Duggal, Ajay
Kelly, Alison
Fan, Stanley L-S.
机构
[1] Hosp Univ La Paz, Madrid, Spain
[2] Univ Ziekenhuizen, Louvain, Belgium
[3] Genzyme Europe Res, Cambridge, England
[4] Royal London Hosp, Renal Dept, London E1 1BB, England
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
引用
收藏
页码:496 / 496
页数:1
相关论文
共 50 条
  • [41] A Review of Sevelamer Hydrochloride in End-Stage Renal Disease Patients on Dialysis
    Spasovski, Goce
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 51 - 55
  • [42] Sevelamer carbonate increases serum bicarbonate in pediatric dialysis patients
    Gonzalez, Elsa
    Schomberg, John
    Amin, Nimisha
    Salusky, Isidro B.
    Zaritsky, Joshua
    PEDIATRIC NEPHROLOGY, 2010, 25 (02) : 373 - 375
  • [43] Comparative Efficacy of Sevelamer Hydrochloride Versus Calcium Acetate on Bone Biomarkers in patients with End Stage Renal Disease on Hemodialysis
    Ahmed, Waqar
    Rizwan-UL-Haq
    Akram, Mateen
    Khan, Sami
    Haider, Saqlain
    Abad-UR-Rehman
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2014, 8 (03): : 769 - 771
  • [44] Results of a randomized, double-blind, cross-over design study of sevelamer hydrochloride (Renagel®) and sevelamer carbonate in chronic kidney disease patients on hemodialysis
    Delmez, James
    Block, Geoffrey
    Bleyer, Anthony
    Robertson, John
    Chasan-Taber, Scott
    Dillon, Maureen
    Blair, Andrew
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 361 - 361
  • [45] Sevelamer carbonate increases serum bicarbonate in pediatric dialysis patients
    Elsa Gonzalez
    John Schomberg
    Nimisha Amin
    Isidro B. Salusky
    Joshua Zaritsky
    Pediatric Nephrology, 2010, 25 : 373 - 375
  • [46] INTRADIALYTIC CALCIUM BALANCE IN HEMODIALYSIS PATIENTS TREATED WITH CALCIMIMETICS AND SEVELAMER HYDROCHLORIDE
    Sonikian, Makrouhi
    Miha, Theodora
    Skarakis, Iakovos
    Karatzas, Ioannis
    Karaitianou, Aphroditi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 497 - 497
  • [47] Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE study)
    Qunibi, WY
    Hootkins, RE
    McDowell, LL
    Meyer, MS
    Simon, M
    Garza, RO
    Pelham, RW
    Cleveland, MVB
    Muenz, LR
    He, DY
    Nolan, CR
    KIDNEY INTERNATIONAL, 2004, 65 (05) : 1914 - 1926
  • [48] Increase in serum magnesium level in haemodialysis patients receiving sevelamer hydrochloride
    Mitsopoulos E.
    Griveas I.
    Zanos S.
    Anagnostopoulos K.
    Giannakou A.
    Pavlitou A.
    Sakellariou G.
    International Urology and Nephrology, 2005, 37 (2) : 321 - 328
  • [49] A randomized, double-blind, cross-over design study of sevelamer hydrochloride (sh, Renagel®) and sevelamer carbonate (SC) in chronic kidney disease patients on hemodialysis
    Delmez, James
    Block, Geoffrey
    Bleyer, Anthony
    Robertson, John
    Chasan-Taber, Scoff
    Dillon, Maureen
    Blair, Andrew
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (04) : A36 - A36
  • [50] Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: effects on vascular calcification, bone and a close look into the survival data
    Frazao, Joao M.
    Adragao, Teresa
    KIDNEY INTERNATIONAL, 2008, 74 : S38 - S43